Factors predicting atracurium reversal time

Acta Anaesthesiologica Scandinavica

Volumn 43, Issue 8, 1999, Pages 834-841

  Kirkegaard Nielsen, Hans ^a,b   Severinsen, I K ^a   Pedersen, H S ^a   Lindholm, P ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antagonism; Atracurium; Mechanomyography; Neostigmine; Nerve stimulation; Neuromuscular monitoring; Neuromuscular relaxants; Train of four, double burst stimulation

Indexed keywords

ATRACURIUM; FENTANYL; HALOTHANE; NEOSTIGMINE; NITROUS OXIDE; THIOPENTAL;

ADULT; ANESTHETIC RECOVERY; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; EVOKED RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MUSCLE TWITCH; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

ADULT; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ATRACURIUM; CHOLINESTERASE INHIBITORS; ELECTRIC STIMULATION; EVOKED POTENTIALS, MOTOR; FEMALE; FENTANYL; FORECASTING; HALOTHANE; HUMANS; LINEAR MODELS; MIDDLE AGED; MUSCLE CONTRACTION; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NITROUS OXIDE; THIOPENTAL; TIME FACTORS; ULNAR NERVE;

EID: 0032874643     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.1999.430809.x     Document Type: Article

References (24)

1. 1. Rupp SM, McCbristian JW, Miller RD et al. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium. Anesthesiology 1986: 64: 711-717.
2. 2. Fox MA; Keens SJ, Utting JE. Neostigmine in the antagonism of the action of atracurium. Br J Anaesth 1987: 59: 468-472.
3. 3. Harper NJN, Wallace M, Hall IA. Optimum dose of neostigmine at two levels of atracurium-induced neuromuscular block. Br J Anaesth 1994: 72: 82-85.
4. 4. Caldwell JE, Robertson EN, Baird WLM. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Br J Anaesth 1986: 58: 1285-1289.
5. 5. Engbæk J, OØstergaard D, Skovgaard LT, Viby-Mogensen J. Reversal of intense neuromuscular blockade following infusion of atracurium. Anesthesiology 1990: 72: 803-806.
6. 6. Gordon KL, Reilly CS. Recovery of neuromuscular function after infusion or intermittent bolus doses of atracurium or vecuronium, Br J Anaesth 1989: 62: 269-273.
7. 7. Smith CE, Donati F, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. Anesthesiology 1989: 71: 37-43.
8. 8. Donati F, Smith CE, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade. Anesth Anlg 1989: 68: 13-19.
9. 9. Gill SS, Bevan DR, Donati F. Edrophonium antagonism of atracurium during enflurane anaesthesia. Br J Anaesth 1990: 64: 300-305.
10. 10. Beemer GH, Bjorksten AR, Dawson PJ et al. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. Br J Anaesth 1991: 66: 469-475.
11. 11. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P et al. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. Can J Anaesth 1996: 43: 932-938.
12. 12. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: A comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988: 69: 272-276.
13. 13. Caldwell JE, Robertson EN, Baird WLM. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery. Br J Anaesth 1987: 59:478-481.
14. 14. Kirkegaard-Nielsen H, Helbo-Hansen H, Severinsen I et al. Response to double burst appears before response to train-of-four stimulation during recovery from non-depolarizing neuromuscular blockade. Acta Anaesthesiol Scand 1996: 40: 719-723.
15. 15. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P et al. Stabilization of the neuromuscular response when switching between different modes of nerve stimulation at surgical degrees of neuromuscular blockade. J Clin Monit 1995: 11: 317-323.
16. 16. Katz RL. Neuromuscular effects of d-tubocurarine, edrophonium and neostigmine in man. Anesthesiology 1967: 28: 327-336.
17. 17. Kirkegaard-Nielsen H, Helbo-Hansen HS, Severinsen IK et al. Comparison of tactile and mechanomyographical assessment of response to double burst and train-of-four stimulation during moderate and profound neuromuscular blockade. Can J Anaesth 1995: 42: 21-27.
18. 18. Donati F, Smith CE, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade. Anesth Analg 1989: 68: 13-19.
19. 19. Magorian TT, Lynam DP, Caldwell JE, Miller RD. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? Anesthesiology 1990; 73: 410-414.
20. 20. Belmont M, Lien C, Quessy S et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995: 82: 1139-1145.
21. 21. Lien C, Schmith V, Belmont M et al. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 1996: 84: 300-308.
22. 22. Baurain MJ, d'Hollander AA, Melot C et al. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology 1991: 74: 474-478.
23. 23. Morita T, Tsukagoshi H, Sugaya T et al. Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane anesthesia. Anesth Analg 1995: 80: 1175-1180.
24. 24. Kirkegaard-Nielsen H, Caldwell J, Abengochea A et al. The influence of anaesthesia technique on neostigmine-induced reversal from cisatracurium-induced neuromuscular block. Abstract book, 10th European Congress of Anaesthesiology, June 30-July 4, 1998, Frankfurt. Abstract PD-E 203.5: S446-S447